Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.45 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.45 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.45 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.32 |
| ▸ | HTR3B | O95264 | 1/20 | 0.32 |
| ▸ | HTR3A | P46098 | 1/20 | 0.32 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.32 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Suriclone SCHEMBL30658453 | 1.00 | ADORA3 (0.45) | ADORA3MAPTRECQLGABRA1GABRA3 | |
| SCHEMBL11486094 | 0.93 | ADORA3 (0.37) | ADORA3MAPTRECQLGABRA1GABRA3 | |
| SCHEMBL11489201 | 0.91 | POLB (0.36) | ADORA3MAPTRECQLGABRA1GABRA3 | |
| Suproclone SCHEMBL29419877 | 0.91 | MAPT (0.36) | ADORA3MAPTRECQLGABRA1GABRA3 | |
| Suproclone SCHEMBL113028 | 0.91 | MAPT (0.36) | ADORA3MAPTRECQLGABRA1GABRA3 | |
| SCHEMBL11842548 | 0.90 | ADORA3 (0.43) | ADORA3MAPTRECQLGABRA1GABRA3 | |
| SCHEMBL11485257 | 0.90 | ADORA3 (0.35) | ADORA3MAPTRECQLGABRA1GABRA3 | |
| SCHEMBL11485464 | 0.90 | ADORA3 (0.35) | ADORA3MAPTRECQLGABRA1GABRA3 | |
| SCHEMBL11486374 | 0.89 | ADORA3 (0.34) | ADORA3MAPTRECQLGABRA1GABRA3 | |
| SCHEMBL11263246 | 0.89 | ADORA3 (0.44) | ADORA3MAPTRECQLGABRA1GABRA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2656 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024102699-A1 | GUANYLATE CYCLASE (GC) STIMULATOR FORMULATIONS AND USES THEREOF | ELANCO US, Inc. (US) | 2024-05-16 | — | — | WO | claimed |
| US-20240148913-A1 | LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE,PREPARATION METHOD THEREFOR, AND USES THEREOF | BEIJING INNO MEDICINE CO., LTD. (CN) | 2024-05-09 | — | — | US | claimed |
| WO-2022086835-A1 | COMBINATION PRODUCTS TO MITIGATE THE RISK OF NON-BENZODIAZEPINE BENZODIAZEPINE AGONIST ADVERSE REACTION AND OVERDOSE | PRESTI MICHAEL (US) | 2022-04-28 | — | — | WO | claimed |
| US-20220117916-A1 | Combination Products to Mitigate the Risk of Non-Benzodiazepine Benzodiazepine Agonist Adverse Reaction and Overdose | SAFERX PHARMACEUTICALS LLC (US) | 2022-04-21 | — | — | US | claimed |
| US-20210145747-A1 | CERASOME DELIVERY SYSTEM FOR TARGETING ACTIVATED CD44 MOLECULE, PREPARATION METHOD AND USE THEREOF | BEIJING INNO MEDICINE CO., LTD. (CN) | 2021-05-20 | — | — | US | claimed |
| US-20200397926-A1 | LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE,PREPARATION METHOD THEREFOR, AND USES THEREOF | BEIJING INNO MEDICINE CO., LTD. (CN) | 2020-12-24 | — | — | US | claimed |
| EP-3744317-A1 | LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF | Beijing Inno Medicine Co., Ltd. (CN) | 2020-12-02 | — | — | EP | claimed |
| US-10689373-B2 | 1,2-substituted cyclopentanes as orexin receptor antagonists | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2020-06-23 | — | — | US | claimed |
| EP-2034951-B2 | REHYDRATABLE PHARMACEUTICAL PRODUCT | BIOCOMPATIBLES UK LTD (GB) | 2020-03-25 | — | — | EP | claimed |
| EP-3610859-A1 | CERASOME DELIVERY SYSTEM FOR USE IN TARGETED ACTIVATION OF CD44 MOLECULE, PREPARATION METHOD THEREFOR AND USE | Beijing Inno Medicine Co., Ltd. (CN) | 2020-02-19 | — | — | EP | claimed |
| US-20050186679-A1 | Method for determining specific groups constituting heparins or low molecular weight heparins | VISKOV CHRISTIAN (FR) | 2005-08-25 | — | — | US | claimed |
| EP-1273301-A2 | Pharmaceutical preparations based on active ingredients susceptible to illicit administration | ALTERGON S.A. (CH) | 2003-01-08 | — | — | EP | claimed |
| WO-2001008670-A2 | METHODS AND COMPOSITIONS FOR ALLEVIATING STUTTERING | INTERNEURON PHARMACEUTICALS, INC. (US) | 2001-02-08 | — | — | WO | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-0123585-B1 | TRANSDERMAL DRUG FORM | RHONE-POULENC SANTE (FR) | 1988-08-31 | — | — | EP | claimed |
| US-4746509-A | DISPERSION IN FILM-FORMING POLYMER | RHONE-POULENC SANTE (FR) | 1988-05-24 | — | — | US | claimed |
| EP-0123585-A2 | Transdermal drug form | RHONE-POULENC SANTE (FR) | 1984-10-31 | — | — | EP | claimed |
| US-3966931-A | TRANQUILIZERS, ANTICONVULSANTS, HYPNOSIS | RHONE-POULENC S.A. (FR) | 1976-06-29 | — | — | US | claimed |
| US-3948917-A | TRANQUILIZERS, ANTICONVULSANTS, DECONTRACTURANTS, HYPNOSIS | RHONE-POULENC S.A. (FR) | 1976-04-06 | — | — | US | claimed |